Cyagen

Using proven methods to bring your custom model idea to life.

General Information
Company Name
Cyagen
Founded Year
2005
Location (Offices)
Santa Clara, United States +2
Founders / Decision Makers
Number of Employees
113
Industries
Biotechnology, Manufacturing, Pharmaceutical
Funding Stage
Series B
Social Media

Cyagen - Company Profile

Cyagen is a 900-employee company headquartered in Santa Clara, California, with additional locations in Germany, Japan, and China. The company's slogan, "Using proven methods to bring your custom model idea to life," encapsulates its mission to provide tailored solutions for biomedical scientists' gene research needs. As the world's largest provider of custom-engineered mouse and rat models, Cyagen offers comprehensive services ranging from DNA vector construction to breeding, characterized by flexibility, top quality, full guarantees, and competitive prices. Moreover, Cyagen provides Contract Research Organization (CRO) services for cell and gene therapy (CGT) research, covering viral vector development, CAR design and construction, disease models, phenotype analysis, and pharmacodynamic evaluations. The company also offers a wide range of stem cell products for research use, including cell lines, media, and differentiation kits. With an array of services that cater to the growing demands of the biomedical research sector, Cyagen presents a compelling opportunity for venture capital firms seeking to invest in the burgeoning field of genetic research and biotechnology. The company's multi-location presence, commitment to quality, and diverse product offerings position it as an attractive prospect for potential investors looking to tap into the rapidly expanding life sciences market.

Taxonomy: Biomedical research, Genetic engineering, Mouse models, Rat models, Gene therapy, Custom model generation, Stem cell products, Cell and gene therapy research, Contract Research Organization, Viral vector development, CAR design, Phenotype analysis, Pharmacodynamic evaluations, Biotechnology services, DNA vector construction

Funding Rounds & Investors of Cyagen (1)

View All
Funding Stage Amount No. Investors Investors Date
Series B $41.00M 4 China Merchants Securities, Grower Venture Capital 26 Feb 2020

Latest News of Cyagen

View All

No recent news or press coverage available for Cyagen.

Similar Companies to Cyagen

View All
Takara Bio USA, Inc. - Similar company to Cyagen
Takara Bio USA, Inc. Empowering gene and cell therapy with comprehensive manufacturing and customer services.
Eureka Biotechnology Co., Limited - Similar company to Cyagen
Eureka Biotechnology Co., Limited Provider of lentiviral vector stable producer cell line system and GMP closed automated equipment for ATMP
Genezen - Similar company to Cyagen
Genezen Accelerating the Pace of Cell Therapy CMC and Clinical Development
RoslinCT - Similar company to Cyagen
RoslinCT Your Advanced Cell & Gene Therapy CDMO Partner
CytoNiche - Similar company to Cyagen
CytoNiche Pioneering 3D micro-organization engineering for advanced stem cell solutions, inspired by Tsinghua University's innovative achievements.